Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caron A Jacobson

Showing results (11-20 of 140) with videos related to

Pageof 14
Sort By:
Blood|November 5, 2011
Time to put the CAR-T before the horseCaron A Jacobson, Jerome Ritz
Hematology/Oncology Clinics of North America|August 10, 2023
CAR T Cells: Past Successes, Current Limitations, and Future OpportunitiesParth S Shah, Caron A Jacobson
Hematology/Oncology Clinics of North America|September 2, 2023
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic LeukemiaParth S Shah, Caron A Jacobson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Rethinking Prognosis and Therapy for Follicular LymphomaCaron A Jacobson, Arnold S Freedman
Oncology (Williston Park, N.Y.)|December 9, 2010
Lymphoma: risk and response after solid organ transplantCaron A Jacobson, Ann S LaCasce
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Is observation dead in follicular lymphoma? Still appropriateCaron A Jacobson, Arnold S Freedman
Advances in Hematology|January 25, 2012
HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cARTCaron A Jacobson, Jeremy S Abramson
Journal of the National Cancer Institute|February 13, 2019
CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future DirectionsBradley D Hunter, Caron A Jacobson
Current Opinion in Oncology|July 24, 2012
Early stage follicular lymphoma, current management and controversiesCaron A Jacobson, Arnold S Freedman
Journal of the National Cancer Institute|December 23, 2011
Follicular lymphoma: to treat or not to treat is no longer the questionCaron A Jacobson, Dan L Longo
Pageof 14

Showing results (11-20 of 140) with videos related to

Sort By:
Pageof 14
Blood|November 5, 2011
Time to put the CAR-T before the horseCaron A Jacobson, Jerome Ritz
Hematology/Oncology Clinics of North America|August 10, 2023
CAR T Cells: Past Successes, Current Limitations, and Future OpportunitiesParth S Shah, Caron A Jacobson
Hematology/Oncology Clinics of North America|September 2, 2023
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic LeukemiaParth S Shah, Caron A Jacobson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Rethinking Prognosis and Therapy for Follicular LymphomaCaron A Jacobson, Arnold S Freedman
Oncology (Williston Park, N.Y.)|December 9, 2010
Lymphoma: risk and response after solid organ transplantCaron A Jacobson, Ann S LaCasce
Journal of the National Comprehensive Cancer Network : JNCCN|March 5, 2015
Is observation dead in follicular lymphoma? Still appropriateCaron A Jacobson, Arnold S Freedman
Advances in Hematology|January 25, 2012
HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cARTCaron A Jacobson, Jeremy S Abramson
Journal of the National Cancer Institute|February 13, 2019
CAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future DirectionsBradley D Hunter, Caron A Jacobson
Current Opinion in Oncology|July 24, 2012
Early stage follicular lymphoma, current management and controversiesCaron A Jacobson, Arnold S Freedman
Journal of the National Cancer Institute|December 23, 2011
Follicular lymphoma: to treat or not to treat is no longer the questionCaron A Jacobson, Dan L Longo
Pageof 14